未登录

G

Guoqiang Wang

peking union medical college

H指数:10

被引数:819

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Nomogram Model for Prognosis of Distant Metastatic DTC Based on Inflammatory and Clinicopathological Factors

JOURNAL OF THE ENDOCRINE SOCIETY

IF3.1

2025-05-010

OAAI

Clinicopathological features affecting the efficacy in 131I ablation therapy of papillary thyroid carcinoma with lymph node metastasis

影响伴淋巴结转移的甲状腺乳头状癌¹³¹I消融治疗疗效的临床病理特征

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2024-07-170

OAAI

Prognostic factors for postoperative papillary thyroid cancer with unexplained elevated Tg: A retrospective study

不明原因Tg升高的甲状腺乳头状癌术后预后因素的回顾性研究

IF3.6

2024-03-011

OAAI

Common DNA methylation changes in biliary tract cancers identify subtypes with different immune characteristics and clinical outcomes

IF8.3

2022-02-0714

OAAI

Co-occurring genomic alterations and immunotherapy efficacy in NSCLC

NPJ PRECISION ONCOLOGY

IF8

2022-01-1827

OAAI

Efficacy and Resistance of Afatinib in Chinese Non-Small Cell Lung Cancer Patients With HER2 Alterations: A Multicenter Retrospective Study

FRONTIERS IN ONCOLOGY

IF3.3

2021-05-0715

OAAI

The tumor immune microenvironment transcriptomic subtypes of colorectal cancer for prognosis and development of precise immunotherapy

GASTROENTEROLOGY REPORT

IF4.2

2020-09-1415

OAAI

Early Onset Immune-Related Adverse Event to Identify Pseudo-Progression in a Patient With Ovarian Cancer Treated With Nivolumab: A Case Report and Review of the Literature

FRONTIERS IN MEDICINE

IF3

2020-07-285

OAAI

Efficacy and safety of PD-1/PD-L1 inhibitors plus nab-paclitaxel for patients with non-small cell lung cancer who have progressed after platinum-based chemotherapy

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

IF4.2

2020-07-0617

OAAI

Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) May Predict the Outcomes of Advanced Non-small-cell Lung Cancer (NSCLC) Patients Treated With Immune Checkpoint Inhibitors (ICIs)

FRONTIERS IN ONCOLOGY

IF3.3

2020-06-2371

OAAI

Depth of Response was Associated with Progression-Free Survival in Patients with Advanced Non-small Cell Lung Cancer treated with EGFR-TKI

Egfr-tki治疗的晚期非小细胞肺癌患者的反应深度与无进展生存期相关

JOURNAL OF CANCER

IF3.2

2019-01-014

OAAI